Nav: Home

New model predicts substantial reduction of malaria transmitting mosquitoes

March 28, 2019

The role of mosquitoes in spreading malaria is the biggest factor behind a recent study that found them to be the 'World's Deadliest Animal'. It is particularly concerning that current measures to control them (the most important of which is the use of insecticide treated bed-nets) are losing potency as mosquitoes are evolving resistance.

The persistence of malaria in large parts of sub-Saharan Africa has motivated the development of novel tools to complement existing control programmes. These include gene-drive technologies to modify mosquito populations, either to reduce them in number or to make the mosquitoes unable to transmit disease.

In new research published today in BMC Biology, from Oxford's Department of Zoology and Oxford Martin School, a team of scientists model the potential of modifying mosquitoes with a gene-drive technology called "driving-Y chromosome" to reduce mosquito populations in a one million square km area of West Africa, including all of Burkina Faso. A driving-Y chromosome has been genetically modified so that the male mosquitoes that carry it produce predominantly male offspring (which also carry the modification). Since only female mosquitoes bite, the spread of this modification will result in less females to transmit the disease, and less mosquitoes overall.

The researchers predict that introductions of driving-Y mosquitoes will cause significant reduction of the target mosquito species in some regions and complete elimination in others.

Lead researcher, Dr Ace North, from the Department of Zoology, said: 'Gene drive holds a lot of promise for malaria control, yet the potential impact at the scale of a country has not been considered much before. We built models to help understand how a gene-drive technology could affect mosquito populations in Burkina Faso, a country with a huge malaria burden. Our results suggest it would have a major impact in reducing malaria.'

The researchers found seasonality to be the most important predictor of the local impact of the gene-drive. Population elimination is more likely in regions with mild dry seasons, while reduction is more likely in regions with strong seasonality. However, even in the most challenging environments, populations were reduced. The model suggests that this approach would have a major impact in reducing malaria.

To reach this conclusion, the scientists fed large and varied data into their models, including:
  • information of more than 40,000 settlements

  • locations of all rivers and lakes - seasonal and permanent

  • historical rainfall data

  • field data estimating mosquito population sizes and mosquito movement rates
They ran a large number of simulations on Oxford University "super-computer" facilities to explore how different factors and assumptions influence the outcome of introductions of genetically modified mosquitoes with a driving-Y chromosome.

This technology, still under development, proposes creating a driving-Y chromosome modification into the most important species of malaria mosquitoes of sub-Saharan Africa.

Professor Charles Godfray, Director of the Oxford Martin School and co-author, said: 'This study suggests that repeated introductions of modified mosquitoes over a few years into a small fraction of human settlements may be sufficient to substantially reduce the overall number of mosquitoes across the entire geographic area.'

Dr Abdoulaye Diabate, a medical entomologist at the Institut de Recherche en Science de la Santé (IRSS), Burkina Faso, said: 'There is evidence that this approach, with the right national and international approvals, could be rolled out within the next 10 years.'

The region to model was selected as it is one of the worst malaria affected areas in Africa and exhibits much of the wide variation in environmental conditions found in West Africa.

The researchers are part of Target Malaria, an international not-for-profit research consortium aiming at developing and sharing new, cost-effective and sustainable genetic technologies to modify mosquitoes and reduce malaria transmission.
-end-
For more information or to request images, please contact the University of Oxford press office at ruth.abrahams@admin.ox.ac.uk / 01865 280730.

Notes to editors

About the University of Oxford

Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the third year running, and at the heart of this success is our ground-breaking research and innovation. Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions. Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 170 new companies since 1988. Over a third of these companies have been created in the past three years.

Target Malaria

Target Malaria is an international not-for-profit research consortium aiming at developing and sharing new, cost-effective and sustainable genetic technologies to modify mosquitoes and reduce malaria transmission. It brings together more than 130 experts from a range of scientific disciplines, risk assessment specialists and regulatory experts, stakeholder engagement and communication teams and project management experts from Africa, North America and Europe.

Source: Mosquito 'World's Deadliest Animal': https://www.gatesnotes.com/Health/Most-Lethal-Animal-Mosquito-Week

University of Oxford

Related Malaria Articles:

Could there be a 'social vaccine' for malaria?
Malaria is a global killer and a world health concern.
Transgenic plants against malaria
Scientists have discovered a gene that allows to double the production of artemisinin in the Artemisia annua plant.
Fighting malaria through metabolism
EPFL scientists have fully modeled the metabolism of the deadliest malaria parasite.
Should we commit to eradicate malaria worldwide?
Should we commit to eradicate malaria worldwide, asks a debate article published by The BMJ today?
Investigational malaria vaccine shows considerable protection in adults in malaria season
An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria -- the deadliest form of the disease -- for the duration of the malaria season, according to new findings published in the Feb.
Why malaria mosquitoes like people with malaria
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria.
Malaria superbugs threaten global malaria control
A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, artemisinin combination therapies (ACTs), according to a study published today in The Lancet Infectious Diseases.
Considering cattle could help eliminate malaria in India
The goal of eliminating malaria in countries like India could be more achievable if mosquito-control efforts take into account the relationship between mosquitoes and cattle, according to an international team of researchers.
Seasonal malaria chemoprevention in Senegalese children lowers overall malaria burden
Giving preventive antimalarial drugs to children up to age 10 during active malaria season reduced the cases of malaria in that age group and lowered the malaria incidence in adults, according to a randomized trial carried out in Senegal and published in PLOS Medicine by researchers from the Université Cheikh Anta Diop, Senegal, the London School of Hygiene & Tropical Medicine, UK, and other collaborators.
How malaria fools our immune system
OIST researchers reconstruct the 3-D structure of a malaria protein in combination with human antibodies.

Related Malaria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.